Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Inspira Technologies Oxy B H N Ltd IINNW


Primary Symbol: IINN

Healthcare Medical Devices
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. The company was formerly known as... see more

Recent & Breaking News (NDAQ:IINN)

Inspira Technologies Granted Patent in Japan for the INSPIRA(TM) ART System's Convertible Dual Lumen Cannula Device and Method of Use

GlobeNewswire 5 days ago

Inspira Technologies Announces Strategic Leap in Lab Capabilities - Accelerating Next-Generation Diagnostics and Blood Technology

GlobeNewswire 11 days ago

Inspira Completes Clinical Study for HYLA(TM) Blood Sensor - Ahead of Regulatory Submission

GlobeNewswire November 13, 2025

Inspira Technologies Nears Final Regulatory Clearance for the ART100 in the UAE, Accelerating Gulf Region Expansion

GlobeNewswire November 6, 2025

Inspira and Bites Form Strategic Alliance to Embed AI as a Core Standard Across Inspira's Global Ecosystem

GlobeNewswire October 22, 2025

Inspira Appoints Former Johnson & Johnson Senior Business Manager as VP of Global Sales and New Board Member from a Leading International Investment Firm

GlobeNewswire October 21, 2025

Inspira Appoints Former Johnson & Johnson Executive as VP of Global Sales and New Board Member from a Leading International Investment Firm

GlobeNewswire October 21, 2025

Inspira Technologies Reports First Half 2025 Financial Results and Issues Business Update

GlobeNewswire October 1, 2025

Inspira to Unveil HYLA(TM) Real-Time Blood Sensor at U.S. ELSO; 97.35% Accuracy Confirmed

GlobeNewswire September 18, 2025

Inspira Announces 97.3% Accuracy Results for HYLA(TM) Blood Sensor, Advancing Toward FDA Submission for Clearance

GlobeNewswire September 11, 2025

Top U.S. Honor Roll Hospital Expands Use of INSPIRA(TM) ART100 System to Lung Transplant Procedures

GlobeNewswire September 2, 2025

Inspira Receives U.S. Patent Approval for the ART500 Core Technology, Key Patent Positions the Company to Dominate $20 Billion Estimated Market

GlobeNewswire August 22, 2025

Inspira Secures $27 Million Government Binding Purchase Order for ART100 Systems with Full Payment in 2025

GlobeNewswire August 19, 2025

Inspira Clarifies Routine Nature of Registration Statement on Form F-3 Filing Performed Every Three Years

GlobeNewswire August 7, 2025

Inspira Activates U.S. Based Consulting Firm to Execute Transformational Initiatives

GlobeNewswire July 31, 2025

Inspira Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire July 18, 2025

Inspira Achieves All Key Objectives in Previously Announced Government Talks, Forging a Pathway to National Adoption and Global Scale-Up of the ART100

GlobeNewswire July 10, 2025

Inspira in High-Level Government Talks to Advance National Integration of the ART100 and Establish a Global Distribution Framework

GlobeNewswire July 7, 2025

Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase

GlobeNewswire July 2, 2025

Inspira's ART100 in Use at Tier-1 U.S. Hospitals, Generating Strong Clinical Interest and Accelerating Sales Discussions

GlobeNewswire June 11, 2025